Clexio Biosciences
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Northern High-Tech Park 10 Hakidma, Yokn...Website
www.clexio.comRevenue
<$5 MillionIndustry
About Clexio Biosciences
Clexio Biosciences is a clinical-stage company focused on developing innovative drugs and technologies for patients with Central Nervous System disorders, particularly Major Depressive Disorder (MDD) and Epilepsy. Their lead drug candidate, CLE-100, is currently undergoing Phase 2 clinical trials in the United States, while a second candidate, CLE-043, is in preclinical development. The company aims to address the unmet needs of patients who have not responded to existing treatments. Clexio's multi-asset pipeline reflects their commitment to advancing novel therapies in neuropsychiatry.Explore more
Clexio Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Clexio Biosciences Tech Stack
A closer look at the technologies used by Clexio Biosciences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Clexio Biosciences
Sign Up For FreeTo access detailed company insights
Clexio Biosciences is a clinical-stage company focused on developing innovative drugs and technologies for patients with Central Nervous System disorders, particularly Major Depressive Disorder (MDD) and Epilepsy. Their lead drug candidate, CLE-100, is currently undergoing Phase 2 clinical trials in the United States, while a second candidate, CLE-... Read More
